Clinical Trial Update: A Study of the Effect of Vinca Alkaloids on c-Jun N-terminal Kinase (JNK) Phosphorylation in Patients With Chronic Lymphocytic Leukemia (CLL) [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluating the effect of vinca alkaloids on JNK phosphorylation in patients with chronic lymphocytic leukemia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Vinca alkaloids (Vinca alkaloids)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Chronic Lymphocytic Leukemia (CLL) | EARLY_Phase 1 | Status: TERMINATED